Literature DB >> 22903250

Aplasia cutis congenita: review of 29 cases and proposal of a therapeutic strategy.

Marie Maillet-Declerck1, Matthieu Vinchon, Pierre Guerreschi, Louise Pasquesoone, Patrick Dhellemmes, Véronique Duquennoy-Martinot, Philippe Pellerin.   

Abstract

INTRODUCTION: Aplasia cutis congenita (ACC) is a rare congenital disorder, which most commonly involves the scalp, and can affect the galea, the pericranium, the bone, and the dura mater. ACC thus is at risk of infection and hemorrhage. There is no consensus over the ideal management and the role for plastic surgery.
MATERIALS AND METHODS: We reviewed retrospectively our experience with 29 patients treated between 1976 and 2011.
RESULTS: The patients were 17 male and 12 female, 25 being referred immediately at birth. The size of the defect ranged from 1 to 192 cm2. Thirteen patients had bone aplasia. Initial conservative treatment was decided in five cases; 15 patients underwent excision-sutures with or without local plasty, 8 underwent pedicled scalp flap, and 1 had skin graft followed by further reconstruction by a free flap. Four patients died in neonatal period because of infection or associated ailments. All others patients achieved complete healing. DISCUSSION: The mortality rate of ACC remains high and increases with the size of bone defect. We propose a therapeutic strategy based on the size of the skin defect and the nature of underlying exposed structures. Cranioplasty is exceptionally necessary because of good spontaneous bone regeneration within few months or years. Cosmetic appearance can be improved later by skin expansion.
CONCLUSION: Aplasia cutis congenita is a rare malformation with sometimes a rapid fatal issue. A precise evaluation of surface and depth of the lesion is essential to decide if and how to operate, in order to provide rapid and efficient coverage. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22903250     DOI: 10.1055/s-0032-1322539

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  8 in total

1.  Dilemmas and challenges in the management of a neonate with Adams-Oliver syndrome with infected giant aplasia cutis lesion and exsanguination: a case-based update.

Authors:  Suhas Udayakumaran; Jimmy Mathew; Dilip Panikar
Journal:  Childs Nerv Syst       Date:  2012-12-29       Impact factor: 1.475

Review 2.  A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita.

Authors:  S R Humphrey; X Hu; K Adamson; A Schaus; J N Jensen; B Drolet
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

Review 3.  Educational paper: neonatal skin lesions.

Authors:  Anthon R Hulsmann; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2013-02-06       Impact factor: 3.183

4.  Congenital skin aplasia on the lower limb in a premature infant with ELBW--case report.

Authors:  Agata Pająk; Anna Szczygieł; Dorota Paluszyńska; Barbara Królak-Olejnik
Journal:  Ital J Pediatr       Date:  2014-11-25       Impact factor: 2.638

5.  Aplasia cutis congenita: Two case reports and discussion of the literature.

Authors:  Alexandros Blionas; Dimitrios Giakoumettis; Elias Antoniades; Evangelos Drosos; Andreas Mitsios; Sotirios Plakas; Georgios Sfakianos; Marios S Themistocleous
Journal:  Surg Neurol Int       Date:  2017-11-09

6.  Congenital cutaneous aplasia of the limbs: A case report.

Authors:  Fatima Amaaoune; Radia Chakiri
Journal:  Ann Med Surg (Lond)       Date:  2022-03-09

7.  Conservative Healing of an 11 × 9-cm Aplasia Cutis Congenita of the Scalp with Bone Defect.

Authors:  Victoria Fröjd; Giovanni Maltese; Lars Kölby; Peter Tarnow
Journal:  J Neurol Surg Rep       Date:  2014-08-11

Review 8.  Aplasia cutis congenita: a report of two cases from National Hospital Abuja, Nigeria and review of the literature.

Authors:  Mariya Mukhtar-Yola; Lauretta Mshelia; Amsa Baba Mairami; Adekunle Tolutope Otuneye; Edith Terna Yawe; Patricia Igoche; Lamidi Isah Audu
Journal:  Pan Afr Med J       Date:  2020-08-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.